Metformin is associated with reduced risk of mortality and morbidity in burn patients compared to insulin

The standard of care for burned patients experiencing hyperglycemia associated with the hypermetabolic response is insulin therapy. Insulin treatment predisposes burn patients to hypoglycemia, which increases morbidity and mortality. Metformin has been suggested as an alternative to insulin therapy...

Ausführliche Beschreibung